Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer
2023
180 citations
Journal Article
green Open Access
Field-Weighted Citation Impact:
46.47
Lorenzo Cohen
·
The University of Texas MD Anderson Cancer Center
Ana M. Aparicio
·
The University of Texas MD Anderson Cancer Center
Amado J. Zurita
·
The University of Texas MD Anderson Cancer Center
Alexandre Reuben
·
The University of Texas MD Anderson Cancer Center
Enrica Marmonti
·
The University of Texas MD Anderson Cancer Center
Stephen G. Chun
·
The University of Texas MD Anderson Cancer Center
Jay P. Reddy
·
The University of Texas MD Anderson Cancer Center
Amol J. Ghia
·
The University of Texas MD Anderson Cancer Center
Sean E. McGuire
·
The University of Texas MD Anderson Cancer Center
Eleni Efstathiou
·
The University of Texas MD Anderson Cancer Center
Jennifer Wang
·
The University of Texas MD Anderson Cancer Center
Jianbo Wang
·
The University of Texas MD Anderson Cancer Center
Patrick G. Pilié
·
The University of Texas MD Anderson Cancer Center
Craig A. Kovitz
·
The University of Texas MD Anderson Cancer Center
Weiliang Du
·
The University of Texas MD Anderson Cancer Center
Samantha J. Simiele
·
The University of Texas MD Anderson Cancer Center
Rachit Kumar
·
The University of Texas MD Anderson Cancer Center
Yerko Borghero
·
The University of Texas MD Anderson Cancer Center
Zheng Shi
·
The University of Texas Health Science Center at San Antonio
Brian F. Chapin
·
The University of Texas MD Anderson Cancer Center
Daniel R. Gomez
·
Memorial Sloan Kettering Cancer Center
Ignacio I. Wistuba
·
The University of Texas MD Anderson Cancer Center
Paul G. Corn
·
The University of Texas MD Anderson Cancer Center
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer | Researchclopedia